JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yen, R.-F.
Right arrow Articles by Chen, T. H.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yen, R.-F.
Right arrow Articles by Chen, T. H.-H.
Journal of Nuclear Medicine Vol. 46 No. 5 770-774
© 2005 by Society of Nuclear Medicine


Clinical Investigations

Whole-Body 18F-FDG PET in Recurrent or Metastatic Nasopharyngeal Carcinoma

Ruoh-Fang Yen, MD1,2, Ruey-Long Hong, MD, PhD3, Kai-Yuan Tzen, MD1, Mei-Hsiu Pan, MD1 and Tony Hsiu-Hsi Chen, PhD2

1 Department of Nuclear Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
2 Institute of Preventive Medicine, National Taiwan University College of Public Health, Taipei, Taiwan
3 Department of Oncology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan

The aim of this retrospective study was to evaluate the sensitivity and prognostic significance of whole-body 18F-FDG PET for nasopharyngeal carcinoma (NPC) patients for whom there was a suspicion of recurrence or metastasis by conventional radiologic or clinical findings during their follow-up examinations. Methods: Whole-body 18F-FDG PET examinations were performed on 64 Taiwanese NPC patients (14 female, 50 male; mean age ± SD, 45.8 ± 13.0 y; age range, 16–75 y) 4–70 mo (mean ± SD, 14.1 ± 13.5 mo) after radiotherapy or induction chemotherapy followed by concurrent chemoradiotherapy from February 1997 to May 2001. The accuracy of 18F-FDG PET detection for each patient was determined by the histopathologic results or other clinical evidence. Results: The sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of 18F-FDG PET images in the diagnosis of NPC recurrence or metastases and secondary primary cancers were 92%, 90%, 92%, 90%, and 91%, respectively. Furthermore, the presence of 18F-FDG hypermetabolism was highly correlated with the survival time of NPC patients. Conclusion: Whole-body 18F-FDG PET is a sensitive follow-up diagnostic tool for the evaluation of NPC recurrences and metastases. It is also an effective prognostic indicator for NPC patients. To determine the optimized utilization of 18F-FDG PET in the follow-up for NPC patients, further cost-effectiveness analysis of 18F-FDG PET in combination with conventional management is necessary.

Key Words: nasopharyngeal carcinoma • whole-body 18F-FDG PET • survival analysis


Related articles in JNM:

THIS MONTH IN JNM

JNM 2005 46: 8a-9a. [Full Text]  



This article has been cited by other articles:


Home page
Br. J. Radiol.Home page
A D KING, B B MA, Y Y YAU, B ZEE, S F LEUNG, J K T WONG, M K M KAM, A T AHUJA, and A T C CHAN
The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis
Br. J. Radiol., April 1, 2008; 81(964): 291 - 298.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
H E O'Donnell, P N Plowman, M K Khaira, and G Alusi
PET scanning and Gamma Knife(R) radiosurgery in the early diagnosis and salvage "cure" of locally recurrent nasopharyngeal carcinoma
Br. J. Radiol., January 1, 2008; 81(961): e26 - e30.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
Y.-K. Chen, C.-T. Su, K.-H. Chi, R.-H. Cheng, S.-C. Wang, and C.-H. Hsu
Utility of 18F-FDG PET/CT Uptake Patterns in Waldeyer's Ring for Differentiating Benign from Malignant Lesions in Lateral Pharyngeal Recess of Nasopharynx
J. Nucl. Med., January 1, 2007; 48(1): 8 - 14.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
S.-C. Chan, T.-C. Yen, S.-H. Ng, C.-Y. Lin, H.-M. Wang, C.-T. Liao, K.-H. Fan, and J. T.-C. Chang
Differential Roles of 18F-FDG PET in Patients with Locoregional Advanced Nasopharyngeal Carcinoma After Primary Curative Therapy: Response Evaluation and Impact on Management
J. Nucl. Med., September 1, 2006; 47(9): 1447 - 1454.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2005 by the Society of Nuclear Medicine.